TdC 190: KPC e outras carbapenemases - podcast episode cover

TdC 190: KPC e outras carbapenemases

Jun 15, 202328 minSeason 4Ep. 190
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨 🔴 Junte-se aos mais de 3.000 assinantes. Assine o Guia, ganhe tempo e atualize-se sem esforço. 🟠 Um serviço de revisão e atualização continuados em clínica médica. A informação que você precisa, do jeito que você prefere. 📚 Confira agora mesmo a edição aberta do Guia TdC sobre a nova diretriz de Insuficiência Cardíaca (IC) da American Heart Association (AHA): https://www.tadeclinicagem.com.br/guia/2/diretriz-de-insuficiencia-cardiaca-aha-2022/.

REFERÊNCIAS: 1. Bush, Karen, and Patricia A Bradford. “Epidemiology of β-Lactamase-Producing Pathogens.” Clinical microbiology reviews vol. 33,2 e00047-19. 26 Feb. 2020, doi:10.1128/CMR.00047-19 (https://pubmed.ncbi.nlm.nih.gov/32102899/ ) 2. Tamma, Pranita D., et al. "Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections." Infectious Diseases Society of America (2023).(https://www.idsociety.org/practice-guideline/amr-guidance/ ) 3. BrCAST Resistência Intrínseca e Fenótipos Raros versão 3.2 do EUCAST Fevereiro 2020 (https://brcast.org.br/wp-content/uploads/2022/09/Resiste%CC%82ncia-Intri%CC%81nseca-e-Feno%CC%81tipos-Raros-BrCAST-16-9-2021.pdf ) 4. Paul M, Carrara E, Retamar P, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521-547. doi:10.1016/j.cmi.2021.11.025 5. Giannella M, Trecarichi EM, Giacobbe DR, et al. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018;51(2):244-248. doi:10.1016/j.ijantimicag.2017.08.019 6. Li YY, Wang J, Wang R, Cai Y. Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):408. Published 2020 Jun 11. doi:10.1186/s12879-020-05133-0

For the best experience, listen in Metacast app for iOS or Android